FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Unichem Pharmaceuticals Doxazosin Tablets Recall

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem…

Unichem Pharmaceuticals USA Inc. · East Brunswick, NJ

Risk level
Class III
Reported by FDA
Feb 18, 2026
Recall ID
D-0306-2026
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Doxazosin Tablets starting Jan 21, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0306-2026 on Feb 18, 2026. Reason: Tablets/Capsules Imprinted with Wrong ID. Status: Ongoing.

Why it was recalled

Tablets/Capsules Imprinted with Wrong ID

Product description

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

Lot numbers, UPCs & expiration codes

Lot # GDSH25006, Exp Date: 08/2027

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0306-2026
Classification
Class III
Status
Ongoing
Recall initiated
Jan 21, 2026
FDA report date
Feb 18, 2026
Quantity
60,000 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Unichem Pharmaceuticals USA Inc.

Original FDA data

Every field from FDA enforcement report D-0306-2026, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Ongoing
Country
United States
Event ID
98321
Address
1 Tower Center Blvd Ste 2200
Code information
Lot # GDSH25006, Exp Date: 08/2027
Postal code
08816-1145
Report date
Feb 18, 2026
Product type
Drugs
Recall number
D-0306-2026
Classification
Class III
Recalling firm
Unichem Pharmaceuticals USA Inc.
Product quantity
60,000 tablets
Reason for recall
Tablets/Capsules Imprinted with Wrong ID
Voluntary / mandated
Voluntary: Firm initiated
Product description
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Distribution pattern
Nationwide
Recall initiation date
Jan 21, 2026
Initial firm notification
Letter
Center classification date
Feb 11, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0306-2026, published Feb 18, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls